Clinical Trial Update: A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE) [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating whether Lactobacillus rhamnosus can reduce colonization by MRSA; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Staphylococcus Aureus Infections

Drugs mentioned

• Lactobacillus rhamnosus (Lactobacillus rhamnosus)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Infection | Phase 2 | Status: COMPLETED